1
Nov 12 (Reuters) – Candel Therapeutics Inc: * CANDEL THERAPEUTICS – ENTERS SECOND AMENDED AND RESTATED SALE AGREEMENT WITH JEFFERIES ON NOV 12, 2026 – SEC FILING * CANDEL THERAPEUTICS – SALE AGREEMENT
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
